Newsletter Subject

Stocks gain in late rally 📈

From

elitetrade.club

Email Address

adam@elitetrade.club

Sent On

Wed, Oct 4, 2023 08:23 PM

Email Preheader Text

Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. It's Wednesday, October 4th. I hope

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. It's Wednesday, October 4th. I hope you had a great trading session. Here's what moved the market today: Markets 📈 Stocks rebounded from a mixed early performance to close with solid gains on Wednesday. The Nasdaq [+1.3%] rallied, while the Dow [+0.3%] and S&P 500 [+00.8%] edged higher. The small-cap Russell 2K [+0.1%] underperformed its large-cap cohorts. Sponsored [Shark Tank's Kevin O'Leary is Putting His Money Here]( If you've ever watched Shark Tank, you know Kevin O'Leary - AKA Mr. Wonderful - is very protective of his money. In fact, he expects to multiply his investments by at least 10x when he gets in... The company featured here is exactly what Mr. Wonderful looks for. In fact, not only did Kevin invest his money in it, he also put his own personal team to work in the company. This opportunity could be part of "the greatest wealth transfer in history," so make your move before you miss out. [Get all the Details HERE >>]( Today's Market-Moving News 🔎 📉 More Downward Revisions for U.S. Job Reports Every month this year, the Labor Dept. has reported job numbers, only to come back and revise them lower a few weeks later. It's the first time in history that every single month of the year through July was hit with a negative revision. Today's Top Winners and Losers 🔥 Oceanpal [OP] $2.15 (30.1%) gave up its gains from a big rally last week that followed reports that Sphinx Investment Corp had acquired a 9.1% stake in the company. A10 Networks [ATEN] $11.04 (27.2%) fell after Craig Hallum cut its price target on the stock from $19 to $15. Inhibikase Therapeutics [IKT] $1.03 (26.4%) received orphan drug designation from the FDA for risvodetinib. Nuvalent [NUVL] $57.51 (+35.5%) released encouraging data from its Phase 1/2 trial of NVL-655 advanced ALK-positive lung cancer and solid tumors. MiNK Therapeutics [INKT] $1.14 (+30.2%) rallied after a Form 4 filing showed CEO Jennifer Buell acquired 695,750 common shares on Sept. 27th. Spectral AI [MDAI] $3.16 (+29.5%) rallied a day after announcing the addition of health expert Deepak Sadagopan to its Board of Directors. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... Text ELITE to 47121 to get our watchlists sent directly to your phone! You can also text CLOSE to 47121 to get the Closing Bell Roundup, too! *Standard message/carrier rates may apply. © Elite Trade Media LLC, 2023. All rights reserved. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Bots click here]( 1969 Alafaya Trail Suite #247 Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](

Marketing emails from elitetrade.club

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

03/12/2024

Sent On

03/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.